Why the study?
ANGPTL8 was previously reported to require ANGPTL3 to inhibit LPL, but the mechanism by which it controls LPL activity remained to be clarified.
Population
In vitro refolded ANGPTL8, ANGPTL3, ANGPTL4, and LPL proteins
Comparison
ANGPTL8 complexed with ANGPTL3 or ANGPTL4 vs ANGPTL4 alone
Design
In vitro mechanistic study
Authors
Loading...
Does not support clinical ANGPTL8 targeting; leaves open its role as LPL regulator pending human studies.
ANGPTL8 acts as a metabolic switch by forming complexes with ANGPTL3 or ANGPTL4 to regulate lipoprotein lipase activity and direct triglyceride energy flow.
Kovrov et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: